To the best of our knowledge, this is the first report on the cytotoxic effects of an amino acid transporter-targeting gemcitabine prodrug, produced by the introduction of threonine, on pancreatic cancer cells. This evidence concerns the gene SLC38A7 and familial pancreatic carcinoma.